Neuromyelitis Optica Spectrum Imaging and Clinical Characteristics

Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune astrocytopathy primarily targeting the optic nerves and spinal cord, often driven by aquaporin-4 antibodies. Clinically, NMOSD presents with severe optic neuritis, longitudinally extensive transverse myelitis and brainstem syndromes, leading to substantial disability if not promptly treated. Conventional MRI typically reveals longitudinal spinal cord lesions extending over three or more vertebral segments and T2 hyperintensities in the optic pathways. Advanced imaging techniques—such as diffusion-weighted and susceptibility mapping, alongside quantitative metrics of neurite density—have refined our understanding of microstructural injury, differentiating NMOSD from multiple sclerosis and other mimics. Recent work has also explored machine-learning approaches to automate lesion classification, while longitudinal studies characterise lesion evolution, repair and residual tissue damage. This body of research underpins earlier diagnosis, tailored immunotherapy and improved prognostic stratification, emphasising the global imperative to harmonise imaging protocols and integrate serological biomarkers in clinical pathways.

Research from Nature Portfolio

Recent studies have leveraged deep learning to distinguish NMOSD from multiple sclerosis on brain MRI. By training a modified ResNet18 network on multi-slice FLAIR images, researchers achieved over 76% accuracy and 0.85 area under the receiver-operating characteristic curve in differentiating the two disorders. Attention-mapping techniques, such as Grad-CAM, highlighted the predominance of white matter lesion characteristics in classification, signalling potential for computer-aided diagnostic support in routine practice and reducing inter-observer variability.

Neuromyelitis Optica Spectrum Imaging and Clinical Characteristics publication trend

The graph below shows the total number of articles in neuromyelitis optica spectrum imaging and clinical characteristics across all publications each year (not limited to Nature Index journals).

Technical terms

Aquaporin-4 antibody: Autoantibody directed against the aquaporin-4 water channel on astrocytes, diagnostic for NMOSD.

FLAIR (Fluid-Attenuated Inversion Recovery): MRI sequence that suppresses cerebrospinal fluid signal to enhance lesion detection.

Diffusion-Weighted Imaging (DWI): MRI technique sensitive to the movement of water molecules, used to assess microstructural integrity.

Longitudinally Extensive Transverse Myelitis (LETM): Spinal cord lesion extending over three or more vertebral segments, characteristic of NMOSD.

Neurite Density Index: Quantitative MRI measure estimating axonal and dendritic density within white matter tracts.

Grad-CAM (Gradient-Weighted Class Activation Mapping): Visualization method in deep learning that identifies image regions contributing most to model predictions.

References

1. Patterns of cerebral damage in multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders—major differences revealed by non-conventional imaging. Brain Communications (2024).
2. Double-negative neuromyelitis optica spectrum disorder. Multiple Sclerosis Journal (2023).
3. Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorder using a deep learning model. Scientific Reports (2023).
4. Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis. PLOS ONE (2015).
5. A Longitudinal Brain Magnetic Resonance Imaging Study of Neuromyelitis Optica Spectrum Disorder. PLOS ONE (2014).
6. Conventional and Advanced Imaging in Neuromyelitis Optica. American Journal of Neuroradiology (2013).